Colgate-Palmolive (NYSE:CL) Given New $104.00 Price Target at UBS Group

Colgate-Palmolive (NYSE:CL - Get Free Report) had its price target dropped by stock analysts at UBS Group from $112.00 to $104.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. UBS Group's target price indicates a potential upside of 17.93% from the company's current price.

Several other analysts also recently issued reports on the stock. TD Cowen reduced their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Thursday, January 9th. Piper Sandler cut their price target on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. Stifel Nicolaus lowered Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their price objective for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $109.00 to $103.00 and set an "overweight" rating for the company in a research note on Thursday. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of "Hold" and an average target price of $102.11.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded up $0.33 during midday trading on Thursday, hitting $88.19. 1,636,218 shares of the stock were exchanged, compared to its average volume of 4,830,292. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a 50 day moving average price of $92.36 and a 200-day moving average price of $97.92. The stock has a market cap of $72.05 billion, a P/E ratio of 25.26, a PEG ratio of 3.01 and a beta of 0.44.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.37% of the company's stock.

Hedge Funds Weigh In On Colgate-Palmolive

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. FMR LLC boosted its stake in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the period. Barclays PLC boosted its position in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares during the last quarter. State Street Corp grew its stake in shares of Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock valued at $5,028,170,000 after acquiring an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB grew its stake in shares of Colgate-Palmolive by 32.5% during the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock valued at $462,121,000 after acquiring an additional 1,247,731 shares in the last quarter. Finally, AQR Capital Management LLC increased its position in shares of Colgate-Palmolive by 58.6% during the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company's stock worth $234,540,000 after acquiring an additional 892,706 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.